Antigenic competition in CD4+ T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial

Journal: Science Translational Medicine

Published: 2019-11-20

DOI: 10.1126/scitranslmed.aaw1673

Affiliations: 16

Authors: 21

Go to article
Institutions Share
Vaccine and Infectious Disease Division (VIDD), FHCRC, United States of America (USA) 0.42
Faculty of Medicine (FMUSP), USP, Brazil 0.05
University Hospital of Lausanne (CHUV), UNIL, Switzerland 0.05
Asociación Civil Selva Amazónica (ACSA), Peru 0.05
Brigham and Women's Hospital (BWH), United States of America (USA) 0.05
Asociación Civil Impacta Salud y Educación, Peru 0.05
Division of Infectious Diseases, CU, United States of America (USA) 0.05
Laboratory of Infectious Disease Prevention, NYBC, United States of America (USA) 0.05
NIH NIAID Division of AIDS (DAIDS), United States of America (USA) 0.05
NIH NIAID Vaccine Research Center (VRC), United States of America (USA) 0.05
Emory Yerkes National Primate Research Center, United States of America (USA) 0.05
Department of Global Health, UW, United States of America (USA) 0.04
UAB Department of Surgery, United States of America (USA) 0.02
UAB Division of Infectious Diseases, United States of America (USA) 0.02
Department of Laboratory Medicine, UW, United States of America (USA) 0.01
Department of Medicine, UW, United States of America (USA) 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER